Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.111 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.01831 | 66 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.09915 | 89 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.21048 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.6439 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.02068 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.726 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.1311 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.06652 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.91621 | 65 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.67928 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.40031 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.06237 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.67838 | 62 |